Does ATEZOLIZUMAB Cause Hypomagnesaemia? 149 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 149 reports of Hypomagnesaemia have been filed in association with ATEZOLIZUMAB (Tecentriq Hybreza). This represents 0.4% of all adverse event reports for ATEZOLIZUMAB.
149
Reports of Hypomagnesaemia with ATEZOLIZUMAB
0.4%
of all ATEZOLIZUMAB reports
56
Deaths
112
Hospitalizations
How Dangerous Is Hypomagnesaemia From ATEZOLIZUMAB?
Of the 149 reports, 56 (37.6%) resulted in death, 112 (75.2%) required hospitalization, and 33 (22.1%) were considered life-threatening.
Is Hypomagnesaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ATEZOLIZUMAB. However, 149 reports have been filed with the FAERS database.
What Other Side Effects Does ATEZOLIZUMAB Cause?
Death (3,591)
Off label use (2,340)
Disease progression (1,828)
Pyrexia (1,599)
Diarrhoea (1,490)
Fatigue (1,253)
Anaemia (1,195)
Pneumonia (1,036)
Nausea (953)
Dyspnoea (938)
What Other Drugs Cause Hypomagnesaemia?
OMEPRAZOLE (1,766)
PANTOPRAZOLE (1,246)
PANITUMUMAB (611)
ESOMEPRAZOLE (591)
CARBOPLATIN (586)
LANSOPRAZOLE (504)
FUROSEMIDE (501)
FLUOROURACIL (477)
METFORMIN (415)
CISPLATIN (395)
Which ATEZOLIZUMAB Alternatives Have Lower Hypomagnesaemia Risk?
ATEZOLIZUMAB vs ATLANTIC SALMON OIL
ATEZOLIZUMAB vs ATOGEPANT
ATEZOLIZUMAB vs ATOMOXETINE
ATEZOLIZUMAB vs ATOMOXETINE\ATOMOXETINE
ATEZOLIZUMAB vs ATORVASTATIN